The short answer is no, you cannot outgrow asthma, but your symptoms may be less severe. Learn when asthma goes into ...

Poorly controlled asthma during pregnancy can lead to serious complications, such as low birth weight, preterm delivery, and ...

More information about the 2025 AAAAI / WAO Joint Congress can be accessed here.

Initially developed for atopic dermatitis, Enveda's lead asset ENV-294 is now showing promise in treating asthma.

Pre-treatment disease trajectories in severe asthma impact treatment-related outcomes, according to a study by Johannes ...

Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed ...

The focus of the presentation will be on the subgroup of patients who have received 100mg bezuclastinib for at least 48 weeks to highlight the symptomatic benefits of long-term use.

Following the devastating fires that swept through Los Angeles in January, concerns are on the rise about the long-term health impacts of smoke inhalation.

Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, plans to begin testing ENV-294, its leading drug candidate developed to treat atopic ...

One of the key changes proposed is the establishment of “cumulative impact” scores. They would represent the totality of ...

Asthma exacerbations cause excessive inflammation ... ETH47’s innovative mechanism of action aims to prevent those exacerbations at their source, potentially improving outcomes for millions ...